Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No direct link found between rising inequality, reduced trust

  • Diversity in developmental trajectories in kids with autism spectrum disorder

  • Common elements of STEM schools identified

  • Financial incentives help pregnant women to quit smoking

  • Grant to develop therapy to protect against nerve agents

  • Up to 2 per cent of Germany's population is dependent on hypnotics

  • Low-frequency deep brain stimulation improves difficult-to-treat Parkinson's symptoms

  • Sexual offending treatment programs in prisons, hospitals are ineffective

  • Fluorescent dyes 'light up' brain cancer cells

  • Stress shared by same-sex couples can have unique health impacts

  •